1/22
Comprehensive vocabulary flashcards covering the core competencies and terminology required for the NAPLEX licensure exam, ranging from pharmacokinetics to ethics.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
NAPLEX
The North American Pharmacist Licensure Examination, a standardized exam administered by the National Association of Boards of Pharmacy (NABP) to assess the knowledge, skills, and abilities of prospective pharmacists.
Pharmacokinetics
The study of what the body does to the drug, encompassing the processes of absorption, distribution, metabolism, and excretion (ADME).
Pharmacodynamics
The study of the biochemical and physiological effects of drugs and their mechanisms of action on the body.
Volume of Distribution (Vd)
A theoretical space in which a drug appears to be distributed, calculated using the formula: Vd=Plasma drug concentrationAmount of drug in the body.
Therapeutic Index
The ratio of the dose that produces toxic effects to the dose that produces therapeutic effects; a higher index indicates a safer drug.
Root Cause Analysis (RCA)
A systematic process used to identify underlying causes of medication errors involving data collection, error identification, cause analysis, and action planning.
Five Rights
A double-checking system in medication administration ensuring the right patient, right drug, right dose, right route, and right time.
Molarity
A measure of solution concentration expressed as the number of moles of solute per liter of solution.
Dilution Formula
The mathematical relationship used to prepare a desired concentration from a stock solution, expressed as C1V1=C2V2.
Allegation Alternate
A calculation method used to determine the specific quantities of two components of different strengths that must be mixed to achieve a desired intermediate strength.
Therapeutic Drug Monitoring (TDM)
The process of measuring drug levels in the blood to ensure therapeutic efficacy and minimize toxicity, especially for drugs with a narrow therapeutic index.
Pharmacogenomics
The study of how genetic variations among individuals affect their response to specific drug therapies.
Type A Adverse Reaction
An unintended, harmful effect of drug therapy that is dose-related and generally predictable (augmented).
Compounding
The art and science of preparing personalized medications tailored to the specific needs of individual patients, such as unique dosages or allergen-free formulations.
USP
The regulatory guidelines providing standards for the preparation of sterile compounded medications.
Aseptic Technique
A compounding method designed to prevent microbial contamination during the preparation of sterile medications, including hand hygiene and cleanroom standards.
Controlled Substances Act (CSA)
A federal law that categorizes drugs into five schedules based on their potential for abuse and medical utility to regulate their manufacture, distribution, and dispensing.
Autonomy
An ethical principle in pharmacy practice stating that patients have the right to make their own healthcare decisions based on accurate information provided by the pharmacist.
Beneficence
An ethical requirement for pharmacists to act in the best interest of the patient and prioritize their welfare.
Antimicrobial Stewardship
Programs and strategies aimed at optimizing the use of antimicrobial agents to reduce resistance, improve patient outcomes, and ensure cost-effective therapy.
Innate Immunity
The body's first line of defense against pathogens, including physical barriers like skin and cellular components like macrophages.
Adaptive Immunity
A specialized immune response involving B-cells and T-cells that develops over time to recognize and respond to specific antigens.
ACE Inhibitors
A class of antihypertensive agents that reduce blood pressure by inhibiting the angiotensin-converting enzyme, which prevents the production of the vasoconstrictor angiotensin II.